全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

多重耐药鲍曼不动杆菌的临床流行特征
Clinical and epidemiological characteristics of multidrug-resistant Acinetobacter baumannii strains

DOI: 10.7652/jdyxb201706017

Keywords: 多重耐药鲍曼不动杆菌,特异性PCR扩增鉴定,临床流行特征,多位点序列分型(MLST)
multidrug-resistant Acinetobacter baumannii
,specific PCR amplification,clinical epidemiological characteristic,MLST

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要:目的 对西安交通大学第一附属医院收集的多重耐药鲍曼不动杆菌进行菌种确认,并检测其临床感染分布特点、耐药性及分子分型特征。方法 收集经VITEK-2鉴定的多重耐药鲍曼不动杆菌47株,利用特异性引物sp2F、sp4F和sp4R通过PCR扩增的方法复检菌株;使用VITEK-2检测鲍曼不动杆菌的药物敏感性;通过多位点序列分型(MLST)方法分析临床菌株的同源性。结果 经过特异性PCR扩增法确认,47株临床样本中有46株为鲍曼不动杆菌,它们大多分离自痰标本,主要收集于重症监护室,呈多重耐药性。MLST分析发现ST195、ST218、ST368及ST208共4种ST型,其中ST368与ST208亲缘关系最近。结论 特异性PCR扩增法可快速、准确地鉴定鲍曼不动杆菌。本院的多重耐药鲍曼不动杆菌主要分布在重症监护室,仅对替加环素等少数抗生素有较高敏感性,存在同源性差异。
ABSTRACT: Objective To confirm the species of multidrug-resistant Acinetobacter baumannii (MRAB) strains collected from our hospital by specific PCR amplification, and further investigate their distribution, antibiotic resistance and molecular classification characteristics. Methods We collected 47 MRAB clinical strains which had been identified by VITEK-2 system, followed by species confirmation using specific primers sp2F, sp4F and sp4R through PCR amplification. Antibiotic resistance characteristics were detected using VITEK-2 system. And the homology of MRAB isolates was analyzed using multilocus sequence typing (MLST). Results We confirmed 46 out of 47 strains as A. baumannii. All of them were multidrug-resistant strains, and the majority of them were found in sputum samples from patients in intensive care units (ICUs). MLST analysis found 4 ST types, namely ST195, ST218, ST368 and ST208. The last two types had the closest genetic relationship. Conclusion Specific PCR amplification is a rapid and accurate method to identify A. baumannii. The MRAB strains in our hospital are mainly distributed in ICUs and are susceptible to only a few antibiotics such as tigecycline

References

[1]  LEI J, HAN S, WU W, et al. Extensively drug-resistant Acinetobacter baumannii outbreak cross-transmitted in an intensive care unit and respiratory intensive care unit[J]. Am J Infect Control, 2016, 44(11):1280-1284.
[2]  YIN T, CHIANG MC, LIAW JJ, et al. Clinical characteristics of Acinetobacter baumannii complex bacteremia in patients receiving total parenteral nutrition[J]. J Chin Med Assoc, 2012, 75(3):102-108.
[3]  HIGGINS PG, LEHMANN M, WISPLINGHOFF H, et al. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3[J]. J Clin Microbiol, 2010, 48(12):4592-4594.
[4]  FOURNIER PE, RICHET H. The epidemiology and control of Acinetobacter baumannii in health care facilities[J]. Clin Infect Dis, 2006, 42(5):692-699.
[5]  胡付品,朱德妹,汪复,等. 2014年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志, 2015, 15(5): 401-410.
[6]  韩蕾,张旭燕,韩少山,等. 临床致病性不动杆菌的分子生物学鉴定[J]. 西安交通大学学报(医学版), 2012, 33(5):611-616.
[7]  HU FP, GUO Y, ZHU DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014[J]. Clin Microbiol Infect, 2016, 22 Suppl 1:S9-14.
[8]  CONSALES G, GRAMIGNI E, ZAMIDEI L, et al. A multidrug-resistant Acinetobacter baumannii outbreak in intensive care unit: Antimicrobial and organizational strategies[J]. J Crit Care, 2011, 26(5):453-459.
[9]  PELEG AY, SEIFERT H, PATERSON DL. Acinetobacter baumannii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008, 21(3):538-582.
[10]  CRISTINA ML, SPAGNOLO AM, OTTRIA G, et al. Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital[J]. Am J Infect Control, 2011, 39(9):790-794.
[11]  HIGGINS PG, WISPLINGHOFF H, KRUT O, et al. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU[J]. Clin Microbiol Infect, 2007, 13(12):1199-1201.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133